2022, Number 2
Percutaneous tracheostomy in patients with SARS-CoV-2
Méndez-Saucedo LM, Mancilla-Mejía FJ, Serrano-Salinas L, Hernández-Mundo A, García-Rodríguez EA
Full text
Language: Spanish
References: 5
Page: 132-135
PDF size: 214.04 Kb.
ABSTRACT
Objective: To determine the safety of the modified percutaneous tracheostomy technique in patients with SARS-CoV-2 from CEMENAV, Mexico City.Materials and Methods: Prospective, cross-sectional, descriptive, comparative study done from May to September 2020, which included patients from the CEMENAV, Mexico City, which were divided into two groups: group 1 included patients without SARS-CoV-2 pneumonia in whom the conventional percutaneous tracheostomy technique was performed. Group 2 included patients with SARS-CoV-2 pneumonia who underwent tracheostomy with a modification of the conventional technique in order to perform a faster, more efficient and safer procedure; limiting exposure to aerosols.
Results: There were included 61 patients, most of whom were men, with a mean age of 59-61 years in both groups. Days of intubation were 11 vs 25 days in no COVID-19 vs COVID-19 groups, respectively (p = 0.0001). Regarding complications with the new technique vs conventional technique, there were no differences (p = 0.974), nor were there comorbidities (p = 0.97). Regarding mortality without differences between both groups, it was found that 16/37 patients with SARS-CoV-2 died at 60 days of follow-up.
Conclusions: Modification of the percutaneous tracheostomy technique in patients with SARS-CoV-2 pneumonia is safe, since there was no difference in complications, mortality and comorbidities.
REFERENCES